IL6 and prostate carcinoma: These factors are particularly important in prostate cancer as both systemic cholesterol homeostasis and pro‐inflammatory cytokines such as IL6 have been implicated in CRPC (Rice et al, 2012; Culig, 2014; Divella et al, 2016).